Related Experiment Video
Updated: Feb 26, 2026

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
Subclinical Atherosclerosis, Cardiac and Kidney Function, Heart Failure, and Dementia in the Very Elderly
Lewis H Kuller1, Oscar L Lopez2,3, John S Gottdiener4
1Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, PA kullerl@edc.pitt.edu.
Insights
Biomarkers like high-sensitivity cardiac troponin T and coronary artery calcium may predict dementia risk in older adults. Lower levels of these markers are associated with a reduced risk of dementia and heart failure (HF).
Area of Science:
- Cardiology
- Neurology
- Geriatrics
Background:
- Heart failure (HF) and dementia are leading causes of disability and death in the elderly.
- Cardiovascular disease (CVD) biomarkers may influence dementia risk in older populations.
- This study investigated the relationship between CVD and HF biomarkers and the risk of dementia and mortality.
Purpose of the Study:
- To test if biomarkers like high-sensitivity cardiac troponin T (hs-cTnT), N-terminal of prohormone brain natriuretic peptide (NT-proBNP), and cystatin C predict risks of death, CVD, HF, and dementia.
- To examine if CVD biomarkers increase HF risk, subsequently increasing dementia risk.
- To determine if a combination of low coronary artery calcium (CAC), low atherosclerosis, and low hs-cTnT (myocardial injury) reduces dementia risk.
Main Methods:
- Utilized data from the Cardiovascular Health Study Cognition Study (Pittsburgh site, 1998-2014).
- Included 532 participants from the original cohort (924 total), with baseline brain MRI in 1992-1994.
- Analyzed 120 incident HF cases and dementia diagnoses, noting the timing of onset.
Main Results:
- Among 532 participants, 120 developed HF, and 72% of these also had dementia.
- In most cases (80 of 87), dementia preceded the diagnosis of HF.
- A combination of low CAC score and low hs-cTnT was significantly associated with a reduced risk of both dementia and HF.
Conclusions:
- Dementia frequently co-occurred with HF, often preceding it.
- Lower levels of hs-cTnT and CAC were linked to a lower risk of dementia, although based on a limited number of events.
Background:
Heart failure (HF) and dementia are major causes of disability and death among older individuals. Risk factors and biomarkers of HF may be determinants of dementia in the elderly. We evaluated the relationship between biomarkers of cardiovascular disease and HF and risk of dementia and death. Three hypotheses were tested: (1) higher levels of high-sensitivity cardiac troponin T, N-terminal of prohormone brain natriuretic peptide, and cystatin C predict risk of death, cardiovascular disease, HF, and dementia; (2) higher levels of cardiovascular disease biomarkers are associated with increased risk of HF and then secondary increased risk of dementia; and (3) risk of dementia is lower among participants with a combination of lower coronary artery calcium, atherosclerosis, and lower high-sensitivity cardiac troponin T (myocardial injury).
Methods And Results:
The Cardiovascular Health Study Cognition Study was a continuation of the Cardiovascular Health Study limited to the Pittsburgh, PA, center from 1998-1999 to 2014. In 1992-1994, 924 participants underwent magnetic resonance imaging of the brain. There were 199 deaths and 116 developed dementia before 1998-1999. Of the 609 participants eligible for the Pittsburgh Cardiovascular Health Study Cognition Study, 87.5% (n=532) were included in the study. There were 120 incident HF cases and 72% had dementia. In 80 of 87, dementia preceded HF. A combination of low coronary artery calcium score and low high-sensitivity cardiac troponin T was significantly associated with reduced risk of dementia and HF.
Conclusions:
Most participants with HF had dementia but with onset before HF. Lower high-sensitivity cardiac troponin T and coronary artery calcium was associated with low risk of dementia based on a small number of events.
Clinical Trial Registration:
URL: http://www.clinicaltrials.gov. Unique identifier: NCT00005133.
Related Concept Videos
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Coronary Artery Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Dementia
The progression of dementia is generally gradual....
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Coronary Artery Disease III: Clinical Manifestations

